Biofarm (BSE:BIO) Cash Flow from Others : lei-7.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Biofarm Cash Flow from Others?

Biofarm's cash flow from others for the three months ended in Dec. 2024 was lei0.0 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was lei-7.4 Mil.

Biofarm Cash Flow from Others Historical Data

The historical data trend for Biofarm's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Cash Flow from Others Chart

Biofarm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

Get a 7-Day Free Trial

-14.66

-13.33

-12.82

-20.12

Biofarm Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow from Others	Get a 7-Day Free Trial															-4.34	-2.15	-4.26	3.35	-

Biofarm Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-7.4 Mil.

Biofarm Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Biofarm's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Biofarm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Cash Flow from Others

Traded in Other Exchanges

N/A

Address

99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212

Website

https://www.biofarm.ro

Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.